Characterization of ovine Toll-like receptor 9 protein coding region, comparative analysis, detection of mutations and maedi visna infection

Developmental and Comparative Immunology

Volumn 35, Issue 2, 2011, Pages 182-192

  Mikula, Ivan ^a,b,b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

^b INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

Author keywords

Comparative analysis; Maedi visna virus; Mutation; Sheep; Substitution; TLR9

Indexed keywords

TOLL LIKE RECEPTOR 9;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; INNATE IMMUNITY; LINKAGE ANALYSIS; MAEDI VISNA; MOLECULAR RECOGNITION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SHEEP; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES COMPARISON; WILD TYPE;

BACTERIA (MICROORGANISMS); OVIS; OVIS ARIES; VISNA/MAEDI VIRUS;

EID: 78449286914     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2010.09.008     Document Type: Article

References (76)

1. Akashi H. Gene expression and molecular evolution. Curr. Opin. Genet. Dev. 2001, 11:660-666.
2. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
3. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
4. Andre S., Seed B., Eberle J., Schraut W., Bultmann A., Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 1998, 72:1497-1503.
5. Bauer M., Heeg K., Wagner H., Lipford G.B. DNA activates human immune cells through a CpG sequence-dependent manner. Immunology 1999, 97:699-705.
6. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H., Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9237-9242.
7. Bell J.K., Mullen G.E., Leifer C.A., Mazzoni A., Davies D.R., Segal D.M. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 2003, 24:528-533.
8. Bowie A.G., Haga I.R. The role of Toll-like receptors in the host response to viruses. Mol. Immunol. 2005, 42:859-867.
9. Brinkmann M.M., Spooner E., Hoebe K., Beutler B., Ploegh H.L., Kim Y.M. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J. Cell Biol. 2007, 177:265-275.
10. Burns N., Holmberg K. Surface charge characterization and protein adsorption at biomaterials surfaces. Trends in Colloid and Interface Science X 1996, 271-275. Springer Berlin, Heidelberg. C. Solans, M. Infante, M. García-Celma (Eds.).
11. Cargill E.J., Womack J.E. Detection of polymorphisms in bovine toll-like receptors 3, 7, 8, and 9. Genomics 2007, 89:745-755.
12. Cheng J., Randall A.Z., Sweredoski M.J., Baldi P. SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Res. 2005, 33:W72-W76.
13. Creighton T. Proteins: Structures and Molecular Properties 1992, W. H. Freeman & Company, New York. second ed.
14. Cutlip R.C., Lehmkuhl H.D., Brogden K.A., Sacks J.M. Breed susceptibility to ovine progressive pneumonia (maedi/visna) virus. Vet. Microbiol. 1986, 12:283-288.
15. Cutlip R.C., Lehmkuhl H.D., Schmerr M.J., Brogden K.A. Ovine progressive pneumonia (maedi-visna) in sheep. Vet. Microbiol. 1988, 17:237-250.
16. Dahlin C., Aronsson H., Wilks H.M., Lebedev N., Sundqvist C., Timko M.P. The role of protein surface charge in catalytic activity and chloroplast membrane association of the pea NADPH: protochlorophyllide oxidoreductase (POR) as revealed by alanine scanning mutagenesis. Plant Mol. Biol. 1999, 39:309-323.
17. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 1998, 160:870-876.
18. Dawson M. Pathogenesis of maedi-visna. Vet. Rec. 1987, 120:451-454.
19. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
20. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., Gejman P.V. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 2003, 12:205-216.
21. Eltahir Y.M., Dovas C.I., Papanastassopoulou M., Koumbati M., Giadinis N., Verghese-Nikolakaki S., Koptopoulos G. Development of a semi-nested PCR using degenerate primers for the generic detection of small ruminant lentivirus proviral DNA. J. Virol. Methods 2006, 135:240-246.
22. Feldmann T., Alex R., Suckow J., Dildrop R., Kisters-Woike B., Muller-Hill B. Single exchanges of amino acids in the basic region change the specificity of N-Myc. Nucleic Acids Res. 1993, 21:5050-5058.
23. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., Gustot T., Quertinmont E., Abramowicz M., Van Gossum A., Deviere J., Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004, 53:987-992.
24. Gundry C.N., Vandersteen J.G., Reed G.H., Pryor R.J., Chen J., Wittwer C.T. Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes. Clin. Chem. 2003, 49:396-406.
25. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41:95-98.
26. Hartmann G., Krieg A.M. CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Ther. 1999, 6:893-903.
27. Hawn T.R., Misch E.A., Dunstan S.J., Thwaites G.E., Lan N.T., Quy H.T., Chau T.T., Rodrigues S., Nachman A., Janer M., Hien T.T., Farrar J.J., Aderem A. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur. J. Immunol. 2007, 37:2280-2289.
28. Hemmi H., Akira S. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 2005, 86:120-135.
29. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
30. Henckaerts L., Pierik M., Joossens M., Ferrante M., Rutgeerts P., Vermeire S. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut 2007, 56:1536-1542.
31. Hosie M.J., Flynn J.N., Rigby M.A., Cannon C., Dunsford T., Mackay N.A., Argyle D., Willett B.J., Miyazawa T., Onions D.E., Jarrett O., Neil J.C. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J. Virol. 1998, 72:7310-7319.
32. Houwers D.J., Visscher A.H., Defize P.R. Importance of ewe/lamb relationship and breed in the epidemiology of maedi-visna virus infections. Res. Vet. Sci. 1989, 46:5-8.
33. Iida K., Akashi H. A test of translational selection at 'silent' sites in the human genome: base composition comparisons in alternatively spliced genes. Gene 2000, 261:93-105.
34. Ivanov I.G., Saraffova A.A., Abouhaidar M.G. Unusual effect of clusters of rare arginine (AGG) codons on the expression of human interferon alpha 1 gene in Escherichia coli. Int. J. Biochem. Cell Biol. 1997, 29:659-666.
35. Jakob T., Walker P.S., Krieg A.M., Udey M.C., Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 1998, 161:3042-3049.
36. Johnson C.M., Lyle E.A., Omueti K.O., Stepensky V.A., Yegin O., Alpsoy E., Hamann L., Schumann R.R., Tapping R.I. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 2007, 178:7520-7524.
37. Kajava A.V., Vassart G., Wodak S.J. Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure 1995, 3:867-877.
38. Keen J.E., Hungerford L.L., Littledike E.T., Wittum T.E., Kwang J. Effect of ewe ovine lentivirus infection on ewe and lamb productivity. Prev. Vet. Med. 1997, 30:155-169.
39. Kennerson M.L., Warburton T., Nelis E., Brewer M., Polly P., De Jonghe P., Timmerman V., Nicholson G.A. Mutation scanning the GJB1 gene with high-resolution melting analysis: implications for mutation scanning of genes for Charcot-Marie-Tooth disease. Clin. Chem. 2007, 53:349-352.
40. Kim C.H., Oh Y., Lee T.H. Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells. Gene 1997, 199:293-301.
41. Klinman D.M. Adjuvant activity of CpG oligodeoxynucleotides. Int. Rev. Immunol. 2006, 25:135-154.
42. Kobe B., Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 1995, 374:183-186.
43. Krieg A.M. Now I know my CpGs. Trends Microbiol. 2001, 9:249-252.
44. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31:2154-2163.
45. Lazarus R., Klimecki W.T., Raby B.A., Vercelli D., Palmer L.J., Kwiatkowski D.J., Silverman E.K., Martinez F., Weiss S.T. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 2003, 81:85-91.
46. Leutenegger C.M., Boretti F.S., Mislin C.N., Flynn J.N., Schroff M., Habel A., Junghans C., Koenig-Merediz S.A., Sigrist B., Aubert A., Pedersen N.C., Wittig B., Lutz H. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif. J. Virol. 2000, 74:10447-10457.
47. Matsushima N., Tanaka T., Enkhbayar P., Mikami T., Taga M., Yamada K., Kuroki Y. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics 2007, 8:124.
48. Mena A., Nichani A.K., Popowych Y., Ioannou X.P., Godson D.L., Mutwiri G.K., Hecker R., Babiuk L.A., Griebel P. Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide. Oligonucleotides 2003, 13:245-259.
49. Morre S.A., Murillo L.S., Bruggeman C.A., Pena A.S. The role that the functional Asp299Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility. J. Infect. Dis. 2003, 187:341-342. author reply 342-343.
50. Mutwiri G., Pontarollo R., Babiuk S., Griebel P., van Drunen Littel-van den Hurk S., Mena A., Tsang C., Alcon V., Nichani A., Ioannou X., Gomis S., Townsend H., Hecker R., Potter A., Babiuk L.A. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet. Immunol. Immunopathol. 2003, 91:89-103.
51. nBLAST, 2009. http://blast.ncbi.nlm.nih.gov/Blast.cgi.
52. Nishiya T., Kajita E., Miwa S., Defranco A.L. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J. Biol. Chem. 2005, 280:37107-37117.
53. Palsson P.A. Maedi and visna in sheep. Front. Biol. 1976, 44:17-43.
54. Parmley J.L., Hurst L.D. How do synonymous mutations affect fitness?. Bioessays 2007, 29:515-519.
55. Pepin M., Vitu C., Russo P., Mornex J.F., Peterhans E. Maedi-visna virus infection in sheep: a review. Vet. Res. 1998, 29:341-367.
56. Perk K., Yaniv A., Gazit A., Demartini J.C. Evaluation of vaccines for ovine lentivirus infection. AIDS Res. Hum. Retroviruses 1996, 12:425-426.
57. Pine S.O., McElrath M.J., Bochud P.Y. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS 2009, 23:2387-2395.
58. Ploumi K., Christodoulou V., Vainas E., Lymberopoulos A., Xioufis A., Giouzeljiannis A., Paschaleri E., Ap Dewi I. Effect of maedi-visna virus infection on milk production in dairy sheep in Greece. Vet. Rec. 2001, 149:526-527.
59. Primer3, 2004. http://frodo.wi.mit.edu/.
60. Pritchard G.C., Done S.H. Concurrent maedi-visna virus infection and pulmonary adenomatosis in a commercial breeding flock in East Anglia. Vet. Rec. 1990, 127:197-200.
61. Rutz M., Metzger J., Gellert T., Luppa P., Lipford G.B., Wagner H., Bauer S. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 2004, 34:2541-2550.
62. Sambrook J., Russell D. Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, New York. third ed.
63. Schroder N.W., Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 2005, 5:156-164.
64. Sparwasser T., Miethke T., Lipford G., Erdmann A., Hacker H., Heeg K., Wagner H. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur. J. Immunol. 1997, 27:1671-1679.
65. Stacey K.J., Sweet M.J., Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 1996, 157:2116-2122.
66. Stern B.V., Boehm B.O., Tary-Lehmann M. Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity. J. Immunol. 2002, 168:6099-6105.
67. TMHMM software, 2009. http://www.cbs.dtu.dk/services/TMHMM-2.0/.
68. Torsteinsdottir S., Carlsdottir H.M., Svansson V., Matthiasdottir S., Martin A.H., Petursson G. Vaccination of sheep with Maedi-visna virus gag gene and protein, beneficial or harmful?. Vaccine 2007, 25:6713-6720.
69. Trambas C., Gallo F., Pende D., Marcenaro S., Moretta L., De Fusco C., Santoro A., Notarangelo L., Arico M., Griffiths G.M. A single amino acid change A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood 2005, 106:932-937.
70. Verthelyi D., Klinman D.M. Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates. Clin. Immunol. 2003, 109:64-71.
71. Weiner G.J., Liu H.M., Wooldridge J.E., Dahle C.E., Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10833-10837.
72. Werling D., Jann O.C., Offord V., Glass E.J., Coffey T.J. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol. 2009, 30:124-130.
73. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J.L., Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 2000, 408:111-115.
74. Xue W.-F., Szczepankiewicz O., Thulin E., Linse S., Carey J. Role of protein surface charge in monellin sweetness. Biochim. et Biophys. Acta (BBA) - Proteins & Proteomics 2009, 1794:410-420.
75. Zhou H., Hickford J.G. Polymorphism of Toll-like receptor 9 (TLR9) gene in sheep. Vet. Immunol. Immunopathol. 2008, 121:140-143.
76. Zhu J., van Drunen Littel-van den Hurk S., Brownlie R., Babiuk L.A., Potter A., Mutwiri G.K. Multiple molecular regions confer intracellular localization of bovine Toll-like receptor 8. Mol. Immunol. 2009, 46:884-892.